Publications by authors named "Gabriele Roccuzzo"

Claim this Profile
T
The burden of skin cancer in heart transplant recipients: Impact of immunosuppressive regimens.
Matteo Marro, Gabriele Roccuzzo, Erika Simonato, Gustavo Alfredo Sobrino Avellaneda, Giulia Rocco

JHLT Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sentinel lymph node biopsies in a patient with multiple melanomas: report of a one-time surgical session.
Gabriele Roccuzzo, Silvia Borriello, Simone Ribero, Pietro Quaglino, Adriana Lesca

Ital J Dermatol Venerol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous and Lymphangitic Infection Caused by in Immunocompromised Patients: A Case Report with a Narrative Review of the Literature.
Tommaso Lupia, Cristina Sarda, Francesca Canta, Marco Casarotto, Guido Accardo, Gabriele Roccuzzo

Life (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 Patients.
Francesco Cavallo, Umberto Santaniello, Elisa Bin, Gabriele Roccuzzo, Silvia Giordano

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG "PARCT".
Rudolf Stadler, Gabriele Roccuzzo, Pablo Ortiz-Romero, Martine Bagot, Pietro Quaglino

Eur J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes.
Chiara Anna Fiasconaro, Alice Carbone, Silvia Giordano, Francesco Cavallo, Paolo Fava, Gabriele Roccuzzo

Diseases· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.
Liyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv, Sara Marchisio, Erika Ortolan

Cells· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and emerging therapies in cutaneous T-cell lymphoma.
Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino

Dermatol Reports· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event.
Silvia Giordano, Federica Repetto, Sara Boskovic, Gabriele Roccuzzo, Michela Ortoncelli

Australas J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment.
Sara Marchisio, Alessia Andrea Ricci, Gabriele Roccuzzo, Eleonora Bongiovanni, Erika Ortolan

J Transl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand eczema: a review of clinical, dermoscopic and histological features.
Elena Zappia, Nicole Macagno, Pietro Quaglino, Gabriele Roccuzzo, Simone Ribero

Ital J Dermatol Venerol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis in Childbearing Age: A Real-Life, Retrospective, Single-Center Study on Anti-IL17 and IL-23 Agents.
Silvia Borriello, Gabriele Roccuzzo, Paolo Dapavo, Nadia Sciamarrelli, Nicole Macagno

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma.
Gabriele Roccuzzo, Paolo Fava, Chiara Astrua, Matteo Giovanni Brizio, Giovanni Cavaliere

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience.
Gabriele Roccuzzo, Nicole Macagno, Pietro Grignani, Chiara Astrua, Matteo Giovanni Brizio

J Clin Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mogamulizumab associated crusted scabies: a rare diagnostic confounder.
Isotta Giunipero DI Corteranzo, Gabriele Roccuzzo, Orsola Crespi, Giovanni Cavaliere, Paolo Fava

Ital J Dermatol Venerol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis.
James P Pham, Nana A L Rosenø, Gabriele Roccuzzo, Ryan C Saal, Alexander Egeberg

J Am Acad Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programme.
Gabriele Roccuzzo, Joana Calvão, Gabor Dobos, Erika Morsia, Pablo Mozas

Br J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic.
Gabriele Roccuzzo, Nicole Macagno, Cristina Sarda, Jelena Pisano, Simone Ribero

Acta Derm Venereol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL17 Secukinumab in hidradenitis suppurativa: A long-term drug survival analysis.
Gabriele Roccuzzo, Federica Repetto, Silvia Giordano, Cristina Sarda, Arianna Comes

Exp Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab-induced red face: a unique presentation.
Gabriele Roccuzzo, Silvia Giordano, Eleonora Bongiovanni, Isotta Giunipero DI Corteranzo, Giovanni Cavaliere

Ital J Dermatol Venerol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Regarding the Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas.
Gabriele Roccuzzo, Rebecca Senetta, Simone Ribero

Dermatology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.
Gabriele Roccuzzo, Cristina Sarda, Valentina Pala, Simone Ribero, Pietro Quaglino

Expert Rev Mol Diagn· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.
Andrea Michelerio, Marco Rubatto, Gabriele Roccuzzo, Marta Coscia, Pietro Quaglino

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the pharmacological management of cutaneous T-cell lymphoma.
Gabriele Roccuzzo, Andrea Roggo, Egle Ramelyte, Sara Marchisio, Chiara Astrua

Expert Opin Pharmacother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective.
Gabriele Roccuzzo, Eleonora Gherardi, Michele Maio, Piergiorgio Malagoli, Angelo Valerio Marzano

Expert Opin Biol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis